Zonisade
Payments companies reported to CMS as associated with Zonisade. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zonisade, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zonisade
These are the largest totals companies reported as associated with Zonisade. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Winkelman | Boston, MA | Sleep Medicine (Psychiatry & Neurology) | $17,393.00 |
| James Wheless | Memphis, TN | Neurology With Special Qualifications In Child Neurology | $5,619.89 |
| Raymond Faught | Birmingham, AL | Neurology (Psychiatry & Neurology) | $3,000.00 |
| Clio Rubinos | New York, NY | Neurology (Psychiatry & Neurology) | $2,365.00 |
| Kathryn Davis | Philadelphia, PA | Epilepsy | $2,250.00 |
| Jay Harvey | Dallas, TX | Epilepsy | $1,500.00 |
| Simon Bessette | Athens, TN | Physician Assistant | $580.27 |
| Rebecca Emory | Atlanta, GA | Pediatrics (Nurse Practitioner) | $543.23 |
| Chaouki Khoury | Atlanta, GA | Neurology With Special Qualifications In Child Neurology | $410.56 |
| Frank Berenson | Atlanta, GA | Neurology (Psychiatry & Neurology) | $398.30 |
Prescribed Zonisade?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.